BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 736994)

  • 1. Prevention of antitumor effect of 5-fluorouracil by hypoxanthine.
    Yoshida M; Hoshi A; Kuretani K
    Biochem Pharmacol; 1978; 27(24):2979-82. PubMed ID: 736994
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythroid induction of K562 human leukemia cells: enhancement by purines.
    Ohlsson-Wilhelm BM; Farley BA; Rudolph NS; Rowley PT
    Arch Biochem Biophys; 1985 Jun; 239(2):567-73. PubMed ID: 4004276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells.
    Piper AA; Nott SE; Mackinnon WB; Tattersall MH
    Cancer Res; 1983 Nov; 43(11):5101-5. PubMed ID: 6616448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidine and hypoxanthine requirements of normal and malignant human cells for protection against methotrexate cytotoxicity.
    Howell SB; Mansfield SJ; Taetle R
    Cancer Res; 1981 Mar; 41(3):945-50. PubMed ID: 6257387
    [No Abstract]   [Full Text] [Related]  

  • 5. A dissection of the inhibitory effects of 5-fluorouracil in Bacillus cereus.
    Doolittle CH; Mandel HG; Hahn GA
    Chemotherapy; 1973; 19(1):22-37. PubMed ID: 4127017
    [No Abstract]   [Full Text] [Related]  

  • 6. Purine and pyrimidine modification of growth and surface properties of baby hamster kidney cells (BHK21/C13).
    Taylor JC; Hill DW; Rogolsky M
    Exp Cell Res; 1975 Feb; 90(2):468-71. PubMed ID: 1167513
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of thymidine and thymidine plus 5-fluorouracil on the growth kinetics of a human lymphoid cell line.
    Murgo AJ; Fried J; Burchenal D; Vale KL; Strife A; Woodcock T; Young CW; Clarkson BD
    Cancer Res; 1980 May; 40(5):1543-9. PubMed ID: 6445227
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficiency of communication between tumour cells in collagen gel cultures.
    Miller FR; McEachern D; Miller BE
    Br J Cancer; 1990 Sep; 62(3):360-3. PubMed ID: 2206943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of thymidylate synthetase activity in development of methotrexate cytotoxicity.
    Moran RG; Mulkins M; Heidelberger C
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5924-8. PubMed ID: 160558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors modifying the synergistic toxicity of deoxycytidine in combination with thymidine plus 5-fluorouracil in HeLa cells.
    Fried J; Perez AG; Doblin JM; Clarkson BD
    Cell Tissue Kinet; 1983 Nov; 16(6):539-48. PubMed ID: 6627345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of a thymidine kinase deficient avian fibroblast cell line derived from a Japanese quail cell line, QT35.
    Niikura M; Narita T; Mikami T
    J Vet Med Sci; 1991 Jun; 53(3):439-46. PubMed ID: 1832032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antitumor activity of the hypoxanthine derivatives ST 789 and ST 689.
    De Simone C; Famularo G; Foresta P; Albertoni C; Arrigoni Martelli E
    Ann N Y Acad Sci; 1993 Jun; 685():344-6. PubMed ID: 8363238
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and antitumor activity of LY288601, the 5,6-dihydro analog of LY231514.
    Barnett CJ; Wilson TM; Grindey GB
    Adv Exp Med Biol; 1993; 338():409-12. PubMed ID: 8304146
    [No Abstract]   [Full Text] [Related]  

  • 14. Colony forming unit suicide in normal and Rauscher leukemic mice given tritiated thymidine in vivo.
    Okunewick JP; Phillips EL
    Exp Hematol; 1974; 2(1):9-15. PubMed ID: 4455510
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and in human cells.
    Evans RM; Laskin JD; Hakala MT
    Cancer Res; 1980 Nov; 40(11):4113-22. PubMed ID: 6162543
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of thymidine and folinic acid protection from methotrexate toxicity in human lymphoid cell lines.
    Browman GP
    Cancer Treat Rep; 1982 Dec; 66(12):2051-9. PubMed ID: 6982753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The increased cytotoxicity in colon adenocarcinoma of methotrexate-5-fluorouracil is not associated with increased induction of lesions in DNA by 5-fluorouracil.
    Lönn U; Lönn S
    Biochem Pharmacol; 1986 Jan; 35(2):177-81. PubMed ID: 3942594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of 1-beta-D-arabinofuranosylcytosine in hepatoma cells by 2'-deoxyadenosine or 2'-deoxyguanosine.
    Harkrader RJ; Boritzki TJ; Jackson RC
    Biochem Pharmacol; 1981 May; 30(10):1099-104. PubMed ID: 6973342
    [No Abstract]   [Full Text] [Related]  

  • 20. The type and time of occurrence of aminopterin-induced chromosome aberrations in cultured Potorous cells.
    Hittelman WN
    Mutat Res; 1973 Apr; 18(1):93-102. PubMed ID: 4697481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.